IL2 and cancer: mRNA-based cell therapeutic agent thatdelivers five mRNAsfor HPV16 protein antigens and immune-stimulating proteins, includingCD86 and membrane bound IL-2 and IL-12, into four different types of engineered immunecells (monocytes, T-cells, B-cells, and NK cells) of cancer patients in a singlestep